0001415889-22-004542.txt : 20220503
0001415889-22-004542.hdr.sgml : 20220503
20220503171046
ACCESSION NUMBER: 0001415889-22-004542
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220502
FILED AS OF DATE: 20220503
DATE AS OF CHANGE: 20220503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adler Reid G.
CENTRAL INDEX KEY: 0001924908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 22888214
MAIL ADDRESS:
STREET 1: C/O VISTAGEN THERAPEUTICS, INC.
STREET 2: 343 ALLERTON AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94090
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-05032022_020513.xml
X0306
4
2022-05-02
0001411685
VistaGen Therapeutics, Inc.
VTGN
0001924908
Adler Reid G.
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHIEF LEGAL OFFICER
Stock Options (right to buy)
1.28
2022-05-02
4
A
0
200000
0
A
2032-05-02
Common Stock
200000
200000
D
25% of the stock options vest on May 2, 2023 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.
/s/ Jerrold D. Doston, Attorney-in-Fact
2022-05-03